Chester County News and Community Website
MALVERN, PA — Venatorx Pharmaceuticals recently granted exclusive commercial rights to Italy’s Menarini Group for its novel antibiotic, cefepime-taniborbactam. The agreement extends to 96 countries in Europe, Latin America, Middle …
Venatorx Pharmaceuticals Strikes Deal with Menarini Group for Global Rights to Cefepime-Taniborbactam Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) has released promising top-line results from its Phase 2b study of ATI-1777, a topical “soft” JAK 1/3 inhibitor developed for treating mild …
Aclaris Therapeutics Announces Promising Phase 2b Results for ATI-1777, Boosting Investor Confidence Read More
EXTON, PA — In a strategic bid to modernize and simplify the hiring process in K12 education, Red Rover has announced the launch of Red Rover Hiring, a software solution …
Red Rover Unveils Innovative Hiring Software to Streamline K12 Recruitment Read More
WAYNE, PA — Teleflex Incorporated (NYSE: TFX), a global provider of medical technologies, has announced a significant addition to its product line that could have notable implications for bariatric surgeons …
Teleflex Expands Its Bariatric Surgery Offering with FDA-Approved Staple Line Reinforcement Read More
MALVERN, PA — In the wake of the Consumer Electronics Show (CES) in Las Vegas, Rajant Corporation and its health-focused division, Rajant Health Incorporated (RHI), have unveiled an innovative edge …
Rajant’s New Edge AI Platform ‘Cowbell’ Set to Revolutionize Broadband Communications Read More
WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a leader in dermatology therapeutics, announced a significant development in its ongoing research for innovative skin cancer treatments. The company confirmed …
Verrica Pharmaceuticals Achieves Milestone in Phase 2 Trial of Groundbreaking Skin Cancer Therapy Read More
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a Pennsylvania-based biopharmaceutical company, has scored a significant regulatory milestone this week with the U.S. Food and Drug Administration (FDA) granting Regenerative Medicine …
Ocugen’s OCU400 Earns FDA’s RMAT Designation, Enhancing Prospects for Retinitis Pigmentosa Treatment Read More
MALVERN, PA — Neuronetics, Inc. (NASDAQ: STIM) this week announced the U.S. Food and Drug Administration (FDA) 510(k) clearance of its NeuroSite™ Coil Placement Accessory. The state-of-the-art tool, designed to …
Neuronetics Secures FDA Clearance for NeuroSite, Streamlining Mental Health Treatments Read More
DOWNINGTOWN, PA — In an exciting new collaboration, Victory Brewing Company is partnering with the beloved Pennsylvania brand, Tastykake, to create a unique brew that will delight fans across the …
Victory Brewing Company and Tastykake Brew Up a Sweet Treat with New Koffee Kake Ale Read More WEST CHESTER, PA — Verrica Pharmaceuticals Inc. (Nasdaq: VRCA), a leading dermatology therapeutics provider, has shared promising top-line results from the Phase 3 trial of TO-208 for molluscum contagiosum (“molluscum”) …
Verrica Pharmaceuticals Announces Positive Results from Phase 3 Trial of TO-208 for Molluscum Treatment in Japan Read More